Panobinostat plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who received prior bortezomib and IMiDs: A predefined subgroup analysis of PANORAMA 1.

Copy For Citation

San Miguel J. F., Hungria V. T. M., Yoon S., Beksac M., Dimopoulos M. A., Elghandour A., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 33
• City: Illinois
• Country: United States Of America
• Ankara University Affiliated: Yes